HealthDay News — For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), according to a study published ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...

The late-stage readout suggests that HRS9531 can hold its own against Eli Lilly’s blockbuster GLP-1/GIP agonist Zepbound, ...

GLP-1s are Glucagon-like peptide-1 agonist drugs that include Ozempic, Wegovy, Mounjaro and Zepbound.

New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...

Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...

It is a transdermal patch that delivers SMGT-GLP-1, a glucagon-like peptide-1 receptor agonist, to help manage weight and control blood sugar levels. How do I use the patch? Apply the patch to a clean ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

The science behind GLP-1 medications and how they work GLP-1 receptor agonists operate by mimicking a natural hormone that regulates blood sugar, slows digestive processes, and signals fullness to ...

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) therapy in idiopathic intracranial hypertension is associated with significant reductions in medication use, symptoms/signs, and procedural ...